Complement-mediated Disorders

• CLINICAL_TRIALS trial_result · 2026-02-03
  Clinical Trial Update: First-In-Human Study To Evaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Escalating Single And Multiple Doses Of CSL040 In Healthy Subjects [Phase 1]

  First-in-human Phase 1 study of CSL040 in healthy subjects completed, evaluating safety, tolerability, pharmacokinetics, and pharmacodynamic…